Log In
Print this Print this

AcuTect P280

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionTechnetium-99m targeting platelet receptor GPIIb/IIIa (CD41/CD61)
Molecular Target Integrin alpha(2b)beta(3) (GPIIb/IIIa) (CD41/CD61)
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsImaging the acute venous thrombosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today